Ketamine has passed phase III trials for treatment resistant depression, apparently based on injection. But a derivative (isomer) of ketamine has passed phase II trials based on an intranasal spray which would be much more practical for people to use.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment